- AAOS
American Academy of Orthopedic Surgeons
- AIC
Akaike information criterion
- AIMS
Arthritis Impact Measurement Scale
- AMSTAR
Assessment of Multiple Systematic Reviews
- AOANJRR
Australian Orthopaedic Association National Joint Replacement Registry
- ASA
American Society of Anesthesiologists
- BIC
Bayesian information criterion
- BMI
body mass index
- CDSR
Cochrane Database of Systematic Reviews
- CEAC
cost-effectiveness acceptability curve
- CEA Registry
Cost-effectiveness Analysis Registry
- CeCoP
ceramic head (cemented stem) on cemented polyethylene cup
- CeLCoC
ceramic head (cementless stem) on cementless hydroxyapatite-coated metal cup (ceramic liner)
- CeLMoP
metal head (cementless stem) on cementless hydroxyapatite-coated metal cup (polyethylene liner)
- CeMoP
metal head (cemented stem) on cemented polyethylene cup
- CENTRAL
Cochrane Central Register of Controlled Trials
- CG
clinical guideline
- CHEC
Consensus on Health Economic Criteria
- CI
confidence interval
- CRD
Centre for Reviews and Dissemination
- DARE
Database of Abstracts of Reviews of Effects
- DSU
Decision Support Unit
- EQ-5D
European Quality of Life-5 Dimensions
- EQ-5D-3
European Quality of Life-5 Dimensions 3 Levels
- FDA
US Food and Drug Administration
- GRADE
Grading of Recommendations, Assessment, Development and Evaluation
- HHS
Harris Hip Score
- HOOS
Hip Disability and Osteoarthritis Outcome Score
- HR
hazard ratio
- HRG4
Healthcare Resource Group v4
- HSCI
Health Service Cost Index
- HSRProj
Health Services Research Projects in Progress
- HTA
Health Technology Assessment
- HUI
Health Utilities Index
- HyMoP
hybrid metal head (cemented stem) on cementless hydroxyapatite-coated metal cup (polyethylene liner)
- ICER
incremental cost-effectiveness ratio
- IPD
individual patient data
- LISOH
Lequesne Index of Severity for Osteoarthritis of the Hip
- LOS
length of stay
- MACTAR
McMaster Toronto Arthritis Patient Preference Questionnaire
- MCID
minimal clinically important difference
- MD
mean difference
- MHRA
Medicines and Healthcare products Regulatory Agency
- MRI
magnetic resonance imaging
- NCC-CC
National Collaborating Centre for Chronic Conditions
- NHP
Nottingham Health Profile
- NHS EED
NHS Economic Evaluation Database
- NICE
National Institute for Health and Care Excellence
- NJR
National Joint Registry for England and Wales
- NLM
National Library of Medicine
- NSAID
non-steroidal anti-inflammatory drug
- OA
osteoarthritis
- ODEP
Orthopaedic Data Evaluation Panel
- OHS
Oxford Hip Score
- OR
odds ratio
- PbR
payment by results
- PICO
population, intervention, comparator/control and outcome
- PRISMA
Preferred Reporting Items for Systematic Reviews and Meta-Analyses
- PROM
patient-reported outcome measure
- PSS
personal and social services
- QALY
quality-adjusted life-year
- RA
rheumatoid arthritis
- RCT
randomised controlled trial
- RR
risk ratio (relative risk)
- RS
resurfacing arthroplasty
- SD
standard deviation
- SE
standard error
- SF-12
Short Form questionnaire-12 items
- SF-36
Short Form questionnaire-36 items
- SHAR
Swedish Hip Arthroplasty Register
- SSI
surgical site infection
- TA
technology appraisal
- THR
total hip replacement
- UCLA
University of California Los Angeles
- UKCRN
UK Clinical Research Network
- VAS
visual analogue scale
- WOMAC
Western Ontario and McMaster University Osteoarthritis Index
- WTP
willingness to pay
Note
This monograph is based on the Technology Assessment Report produced for NICE. The full report contained a considerable number of data that were deemed commercial-in-confidence. The full report was used by the Appraisal Committee at NICE in their deliberations. The full report with each piece of commercial-in-confidence data removed and replaced by the statement ‘commercial-in-confidence information (or data) removed’ is available on the NICE website: www.nice.org.uk.
The present monograph presents as full a version of the report as is possible while retaining readability, but some sections, sentences, tables and figures have been removed. Readers should bear in mind that the discussion, conclusions and implications for practice and research are based on all the data considered in the original full NICE report.
